LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
Sleep Apnea Solution author Dylan Petkus, MD, has developed a non-device, behavior-based alternative approach to sleep apnea.
Daily Mail on MSN
New treatment for sleep apnea relieves deadly disorder without bulky breathing device
In a recent trial, 60 percent of patients using the device had fewer breathing interruptions and less daytime fatigue. For ...
Add Yahoo as a preferred source to see more of our stories on Google. A Black woman sleeps peacefully surrounded by pills, charts, and various sleep devices. Sleep, the thing we all do each night, has ...
If you’ve been diagnosed with sleep apnea, you likely already know that a continuous positive airway pressure (CPAP) device is considered the gold-standard treatment. And while that’s true, it can ...
Sleep apnea sufferers may soon have a new path to a good night’s sleep. A Massachusetts biotech startup is preparing to file for FDA approval of a once-nightly pill that could become the first ...
Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition will regularly stop breathing during sleep as the muscles in their throat ...
Hosted on MSN
Sleep apnea care is getting a smart makeover
Sleep apnea is no longer a condition treated with a one-size-fits-all mask. Advances in wearable tech, AI, and new therapies are making diagnosis and treatment more personal, comfortable, and ...
Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by pauses in respiratory effort related to an unstable ventilatory system. This ...
DeTar Healthcare System is pleased to announce that the upper airway stimulation system, an advanced treatment option for patients with obstructive sleep apnea (OSA), is now available through Dr.
A major new study has found a notable connection between untreated sleep apnea and an increased risk of Parkinson’s disease. A team of researchers from Oregon Health and Science University (OHSU) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results